Retail entity
Every one of those 1 sits in a single category, earnings. Blue Buffalo is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 1 original sources per story, versus 2.3 across the same-window beat baseline.
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, earnings. Blue Buffalo is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 1 original sources per story, versus 2.3 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.9 for that window. GLP-1 Medications appears in 1 tracked Retail story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 Retail stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GLP-1 Medications. Shared-story counts are live from our verified record — not editorial picks.
General Mills shares tumbled after the company lowered its full-year financial guidance, citing persistent volume pressures and shifting dietary habits. The food giant is aggressively retooling its portfolio to appeal to health-conscious consumers and those utilizing GLP-1 weight-loss medications.
Source: The Wall Street Journal
GLP-1 Medications is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
